The glycoprotein tenascin C (TNC), a protein that inhibits the interaction between cell–ECM, was shown to be a target of miR-355, and loss of miR-355 potentiated tumor cells’ metastatic abilities (31). This evidence concerns the gene TNC and neoplasm.